4//SEC Filing
Hardy Nathan 4
Accession 0001562180-22-002425
CIK 0001770121other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 9:03 AM ET
Size
5.5 KB
Accession
0001562180-22-002425
Insider Transaction Report
Form 4
Hardy Nathan
SVP, Chief Financial Officer
Transactions
- Award
Stock Options (Right to Buy)
2022-03-03+225,000→ 225,000 totalExercise: $5.70Exp: 2032-03-02→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001830053
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 9:03 AM ET
- Size
- 5.5 KB